Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

The liver is the largest internal organ of the human body. This vital organ is crucial for the processes of digestion, ...

Hepatitis B vaccination stands as a powerful tool against liver cancer, particularly hepatocellular carcinoma, by preventing ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

Over 80% of hepatocellular carcinoma (HCC) – the third-leading cause of cancer deaths globally – emerges from advanced liver fibrosis or cirrhosis. A comprehensive review in Hepatology International ...

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over 1·5 million in 2050. This scenario, and all the attendant harms to health and ...

AstraZeneca has received a positive recommendation from NICE for the use of Imfinzi (durvalumab) with Imjudo (tremelimumab) ...

Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.